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Abstract: BACKGROUND  The amygdala plays a central role in detecting and responding to fear related 
stimuli. A number of recent studies have reported decreased amygdala activation in schizophrenia to 
emotional stimuli (such as fearful faces) compared to matched neutral stimuli (such as neutral faces). Here 
we have investigated whether the apparent decrease in amygdala activation in schizophrenia could actually 
derive from increased amygdala activation to the neutral comparator stimuli.
METHODS Nineteen patients with schizophrenia and 24 matched control participants viewed pictures of 
faces with either fearful or neutral facial expressions, and a baseline condition, during functional magnetic 
resonance imaging scanning.
RESULTS Patients with schizophrenia showed a relative decrease in amygdala activation to fearful faces 
when compared to neutral faces. However this difference resulted from an increase in amygdala activation 
to the neutral faces in patients with schizophrenia, not from a decreased response to the fearful faces.
CONCLUSIONS Patients with schizophrenia show an increased response of the amygdala to neutral faces. 
This is sufficient to explain their apparent deficit in amygdala activation to fearful faces compared to neutral 
faces. The inappropriate activation of neural systems involved in fear to otherwise neutral stimuli may 
contribute to the development of psychotic symptoms in schizophrenia.
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Fear of faces in schizophrenia
Hall et al looked at the response of the amygdala, a brain region mediating fear, to 
faces in control subjects and participants with schizophrenia. They found that control 
subjects show amygdala activation to fearful faces, but not neutral faces. However 
patients with schizophrenia activated the amygdala fear system to both neutral and 
fearful faces. These results suggest that people with schizophrenia may perceive 
neutral faces as fearful, potentially contributing to the development of psychotic 
symptoms. 
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Abstract
Background  The amygdala plays a central role in detecting and responding to fear 
related stimuli. A number of recent studies have reported decreased amygdala 
activation in schizophrenia to emotional stimuli (such as fearful faces) compared to 
matched neutral stimuli (such as neutral faces). Here we have investigated whether the
apparent decrease in amygdala activation in schizophrenia could actually derive from 
increased amygdala activation to the neutral comparator stimuli.
Methods Nineteen patients with schizophrenia and 24 matched control participants
viewed pictures of faces with either fearful or neutral facial expressions, and a 
baseline condition, during functional magnetic resonance imaging scanning.
Results Patients with schizophrenia showed a relative decrease in amygdala 
activation to fearful faces when compared to neutral faces. However this difference 
resulted from an increase in amygdala activation to the neutral faces in patients with 
schizophrenia, not from a decreased response to the fearful faces.
Conclusions Patients with schizophrenia show an increased response of the amygdala 
to neutral faces. This is sufficient to explain their apparent deficit in amygdala 
activation to fearful faces compared to neutral faces. The inappropriate activation of 
neural systems involved in fear to otherwise neutral stimuli may contribute to the 
development of psychotic symptoms in schizophrenia.
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Introduction
The amygdala plays a central role in detecting and responding to fear-provoking 
stimuli (1). Individuals with bilateral lesions of the amygdala show a marked 
impairment in their ability to recognise fear from faces, and neuroimaging studies 
have confirmed that the amygdala shows greater activation to the presentation of faces 
expressing fear than to matched neutral faces (1, 2).
There is evidence of structural and functional abnormalities of the amygdala in 
schizophrenia (3). A number of functional neuroimaging studies have reported 
decreased amygdala activation in patients with schizophrenia compared to control 
subjects (4-13). Decreased amygdala activation in schizophrenia has been particularly 
shown in studies in which the response of the amygdala to an emotional stimulus 
(such as a face expressing fear) has been compared to a matched neutral stimulus 
(such as a neutral face) (7-9, 12, 13). These results have been interpreted as revealing 
a deficit in amygdala activation in response to emotion in patients. 
The finding of decreased amygdala activation in patients with schizophrenia, 
especially those with paranoid symptoms, poses a paradox. Why should it be that 
patients whose clinical presentation is characterised by increased fear and arousal
have decreased activation of the key brain region involved in fear? One possibility is 
that the apparent decrease in amygdala activation in response to fearful stimuli in 
these individuals actually derives from an increase in amygdala activation to the 
neutral comparator stimuli (3). Amygdala activation is known to occur to the
presentation of neutral stimuli (14) and there is evidence that this response may be 
enhanced in individuals with schizophrenia (15). In the current study we have directly 
addressed the hypothesis that the apparent deficit in amygdala activation in 
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schizophrenia to emotional stimuli actually derives from an increase in amygdala 
response to the neutral comparator stimuli. 
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Materials and Methods
Participants
Twenty-four patients meeting DSM-IV diagnostic criteria for schizophrenia and 24 
matched control subjects participated in the study. One patient was excluded due to 
the presence of a benign cerebral cyst and four were excluded due to failure to make 
behavioural responses. Full details of subject recruitment and characteristics are given 
in the Supplementary Methods.
Experimental design
A block design was used with three conditions: fear, neutral and baseline. During fear 
blocks 6 faces expressing the emotion of fear were presented for 3.5s each; during 
neutral blocks the same faces showing a neutral emotional expression were presented,
and during baseline blocks participants were instructed to look at a fixation cross. 
Participants were required to select the gender of the face by pressing a button. The 
full task consisted of two runs each comprising 3 fear blocks (25s each), 3 neutral 
blocks (25s) and 7 interleaved blocks of the baseline condition (12.5s). Pilot data
demonstrated that maximal amygdala activation was seen in the first run, consistent 
with previous studies (2), so analysis was primarily focussed on this period.
Image acquisition, processing and analysis
Details are given in the Supplementary Methods. Image analysis was conducted using 
SPM2 (www.fil.ion.ucl.ac.uk/spm). Contrast images were generated for each 
participant for the contrasts of interest (fear versus neutral, fear versus baseline and 
neutral versus baseline). One contrast image per participant was then entered into a 
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second-level random effects analysis for each contrast of interest to examine regions 
of significant difference between groups using a t-test. All statistical maps were 
thresholded at a level of P<0.001 uncorrected and regions were considered significant 
at P<0.05 at the cluster level, corrected for multiple comparisons. A region of interest 
(ROI) analysis was conducted for the bilateral amygdala.
Behavioural tests of emotion recognition
A standardised test of recognition of the six basic facial emotions facial emotion 
recognition was conducted after the scanning session (see Supplementary Methods).
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Results
Demographics and behavioural responses in the scanner
There were no significant differences between the groups in terms of age (F1,41=0.9, 
P>0.3), NART IQ (F1,41=1.3, P>0.2) or gender (Fisher’s exact test, P=1.0). Both 
groups performed the incidental gender discrimination task to high degree of accuracy 
(patients 91% correct (SD 13%), controls 98% correct (SD 3%)), although the 
schizophrenia group did show a deficit in accuracy of gender judgments compared to 
controls (F1,41=6.4, P<0.05). 
Response to fearful faces versus neutral faces
Patients with schizophrenia showed a relative decrease in left amygdala activation 
compared to control participants in the contrast of fearful faces versus neutral faces 
(P<0.05 corrected within amygdala ROI; Table 1 and Figure 1). In addition patients 
showed less activation relative to controls in the right fusiform gyrus and right lingual 
gyrus (Table 1).
Response to neutral faces versus baseline
Patient showed greater activation of the amygdala to neutral stimuli than the control 
group (P<0.01 corrected within an amygdala ROI; Table 1 and Figure 1). Patients also
showed relatively greater activation than controls in the right lingual gyrus, fusiform 
gyrus and posterior cingulate (Table 1).
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Response to fearful faces versus baseline
There was no significant difference in activation of the amygdala or other brain 
regions between patient and control groups in the contrast of fearful faces versus 
baseline (Table 1).
Comparison of amygdala activation across the task conditions
We extracted data for activation in the left amygdala for both task conditions (fear and 
neutral) relative to baseline and performed an ANOVA with group as a between 
subjects factor and emotion as a within subjects factor (Figure 2). This analysis 
revealed a significant group by emotion interaction (F1,41=4.9, P<0.05). Planned post-
hoc t-tests confirmed that this derived from greater activation of the amygdala in the 
schizophrenia group to neutral faces (P<0.01), with no difference between groups in 
amygdala activation to fearful faces (P=0.4). 
Correlation analyses
Correlation analyses were performed to assess whether left amygdala activation (fear 
versus baseline or neutral versus baseline) was related to medication dose, PANSS 
total score, PANSS positive or PANSS negative symptoms, PANSS anxiety and 
depressive symptoms or gender judgment performance. None of these correlations 
was significant. 
Amygdala activation over time
A comparison of amygdala activation between the first and second task runs showed 
significant habituation of amygdala activation over time, with group differences only 
apparent in the first run (Supplementary Figure 1).
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Functional connectivity analysis
Additional analysis of functional connectivity between the amygdala and fusiform 
gyrus is presented in Supplementary Results and Supplementary Figure 2.
Performance on tests of emotion recognition
Performance of the patient and control groups on the test of emotion recognition was 
analysed using an ANOVA with group as a between-subjects factor and emotion as a 
within-subjects factor and showed a significant overall effect of group (F1,41=7.0, 
P=0.01) and emotion (F5,205=32.1, P<0.001) and a trend to a group by emotion 
interaction (F5,205=2.2, P=0.054). Post-hoc t-tests showed a significant impairment in 
the recognition of the emotion of fear in patients with schizophrenia relative to control 
participants (P<0.01), with this emotion most commonly mistaken for surprise. There 
was no correlation of patient IQ with fear recognition performance.
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Discussion
A number of neuroimaging studies have reported decreased activation of the 
amygdala to emotional stimuli compared to neutral stimuli in schizophrenia (3). We 
have investigated this effect by examining amygdala response to fearful and neutral 
faces in patients with schizophrenia and control subjects. We found that whilst 
patients did not differ significantly from controls in their amygdala response to fearful 
faces, they showed increased activation of the amygdala to neutral faces.
Patients with schizophrenia experiencing psychotic symptoms, especially 
paranoid beliefs, characteristically have increased levels of fear and arousal. The 
amygdala plays a central role in mediating fear and arousal and it is therefore 
paradoxical that previous studies have shown a decrease in amygdala activation in 
schizophrenia (7-9, 12, 13). The present findings provide a resolution to this paradox 
by showing that the apparent deficit in amygdala activation in individuals with 
schizophrenia can in fact be explained by increased amygdala response to the neutral 
comparator stimuli. This finding is supported by other studies which have shown
increased medial temporal lobe activation in response to neutral stimuli in individuals
with schizophrenia (15-17). Notably enhanced amygdala activation to neutral faces is 
also seen in children, suggesting the current findings may have a neurodevelopmental 
origin (18).
The present results help explain the findings of behavioural studies, which 
have typically shown deficits in the recognition of facial emotions in patients with 
schizophrenia, especially for negative emotions such as fear. Our findings suggest that 
the behavioural deficits may derive from an indiscriminate activation of the amygdala 
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to both fearful and non-fearful facial stimuli rather than a failure to activate the 
amygdala to fearful faces.
Patients with psychosis ascribe affective importance to stimuli and events that 
would generally be considered neutral. An influential theoretical model of the origin 
of psychosis is that it represents a state characterized by the aberrant attribution of 
salience to internal and external events (19). A related hypothesis posits amygdala 
hyper-activation, related to increased dopamine responsiveness, as a key pathogenic 
process in schizophrenia causing exaggerated affective drive to govern behavioural 
response selection (20). The current findings support these theories by demonstrating
increased activation of the amygdala to neutral stimuli in schizophrenia, which may 
contribute to liability for psychosis.
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Figure legends
Figure 1. (A) Statistical parametric map (SPM) showing relatively greater amygdala 
activation in control participants than participants with schizophrenia in the contrast 
of fearful faces versus neutral faces. SPM thresholded at P<0.001 uncorrected. 
Crosshairs show the peak voxel within the left amygdala (co-ordinates -22 -1 -12). (B) 
SPM showing greater amygdala activation in participants with schizophrenia than 
control participants in the contrast of neutral faces versus baseline. SPM thresholded
at P<0.001 uncorrected, KE=50. Crosshairs show the peak voxel within the left 
amygdala (co-ordinates -17 -2 -15). 
Figure 2. Plot of mean within group response in the left amygdala for the main 
contrasts of interest. Data were extracted from a volume of interest centered on the 
voxel of peak difference in the contrast of neutral versus baseline (8mm sphere of 
centre -22 -1 -12) for each of the three contrasts: Neutral versus Baseline (N vs B); 
Fear versus Baseline (F vs B) and Fear versus Neutral (F vs N). CON = control group. 
SCH = schizophrenia group. Error bars show SEM.
Figure 3. Recognition of basic facial emotions. CON = control group. SCH = 
schizophrenia group. ANG = anger, DIS = disgust, FEAR = fear, HAP = happiness, 
SAD = sadness, SUR = surprise. ** indicates a significant difference between groups 
at P < 0.01. Error bars show SEM.
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Cluster P 
(Corrected)
Extent
(Voxels)
Z Peak voxel Region
Fear versus Neutral:
Controls > Patients 
0.004 419 4.34 14 -55 -2 R lingual gyrus/calcarine sulcus
0.022 283 4.17 33 -39-11 R fusiform gyrus/parahippocampal gyrus
0.026* 18 3.33 -22 -1 -12 L amygdala
Neutral versus Baseline:
Controls < Patients
0.021 312 4.03 10 -53 -10 R lingual gyrus/posterior cingulate
<0.001 766 3.92 10 -76 -7 R fusiform gyrus/lingual gyrus
0.009* 61 4.11 -17 -2 -15 L amygdala
Fear versus Baseline:
No significant differences between groups
*within amygdala ROI (small volume correction)
Table 1.  Random effects analysis for main contrasts of interest. Corrected cluster 
level P values are shown. 
Table 1
Supplementary Methods
Participants
Twenty-four patients meeting DSM-IV diagnostic criteria for schizophrenia 
participated in the study, recruited from both inpatient and outpatient populations. 
Diagnoses were made by clinical consensus amongst clinicians highly experienced in 
working with patients with psychosis and was confirmed from case-notes using 
OPCRIT criteria (1). Exclusion criteria were age under 18 or over 65, neurological 
disease, dependence on alcohol or non-prescribed drugs, and other concomitant axis I 
or axis II disorder. Sixteen were men and eight were women. One subject was 
excluded due to the presence of a benign cerebral cyst and four individuals were 
excluded prior to analysis due to a failure to make any behavioural responses in the 
scanner. The remaining 19 individuals in the patient group (twelve men and seven 
women) had a mean age of 37.7 years (SD 8.4) and a mean pre-morbid IQ as assessed 
by the National Adult Reading Test (NART) (2) of 111.6 (SD 10.1). All patients were 
Caucasian, 17 were right handed and 2 were left handed. All were treated with
antipsychotic medication (16 with atypical antipsychotics) with a mean 
chlorpromazine equivalent dose of 496mg (SD 377mg). Symptoms were rated on the 
day of the scanning session using the positive and negative syndrome scale (PANSS) 
(3) and the mean PANSS score was 46.8 (SD 8.5). Mean positive syndrome score on 
the PANSS was 12.3 (SD 4.5) with 15 out of the 19 individuals scoring 3 or greater 
on one or more positive syndrome items. Mean negative syndrome score on the 
PANSS was 11.8 (SD 3.4).
Twenty-four healthy control volunteers were recruited from the same regions 
and communities as the patients themselves. None of these subjects reported any 
Supplemental Methods
personal history of psychiatric illness or any family history of psychosis. Sixteen were 
men and eight were women; mean age was 35.1 years (SD 9.7), and mean IQ was 
114.5 (SD 6.5). All control participants were Caucasian and right handed. Control 
participants were screened for any family or personal history of psychiatric illness and 
were additionally subject to the same exclusion criteria as the patients.
The study was approved by the local ethics committee and after complete 
description of the study written informed consent was obtained from all participants.
Task design
During fear and neutral blocks participants were initially presented with a 1s visual 
prompt (“Gender?”) followed by six greyscale pictures of faces from the Ekman and 
Friesen series (4) each presented for 3.5s in a random order with a 0.5s inter-stimulus 
interval. Three of the faces were male and three were female in each block. 
Participants were required to select the gender of the face by pressing a button. The 
alternative response choices (“Male” and “Female”) were shown on the screen. 
Pictures of the same individuals were shown in both the fear blocks and neutral blocks, 
differing only in the emotion shown (fearful or neutral expressions respectively). The 
order of presentation of fear and neutral blocks was counterbalanced across subjects. 
A block design was chosen because of the statistical power afforded by this approach, 
and the fact that it has proven effective in demonstrating amygdala activation in 
previous studies (5, 6). An implicit task was selected because increasing cognitive 
task demands has previously been shown to decrease limbic, and in particular 
amygdala activation (7).
Image acquisition
Imaging was performed at the SFC Brain Imaging Research Centre in Edinburgh 
using a GE 1.5TE Signa scanner (GE Medical, Milwaukee, WI, USA). After a 
localiser scan participants underwent functional scanning (99 volumes; Field of View 
22cm; Time to Echo (TE) 40ms; Volume acquisition time (TR) 2.5s). Interleaved 
axial slices were acquired with a thickness of 5mm with no gap and matrix size of  64 
x 64. The first four EPIs were discarded to avoid T1 equilibrium effects. 
Image processing and analysis
The EPI images were reconstructed offline in ANALYZE format (Mayo Foundation, 
Rochester, MN, USA). Image analysis was conducted using SPM2 (Statistical 
Parametric Mapping; Wellcome Department of Cognitive Neurology and 
collaborators, Institute of Neurology, London, UK). Pre-processing consisted of re-
orientation of the images and realignment to the mean EPI image, followed by 
normalisation to the standard Montreal Neurological Institute EPI template and spatial 
smoothing using a Gaussian kernel (8mm3 full-width at half-maximum). Images from 
all subjects were inspected to exclude susceptibility artefacts in the medial temporal 
lobe. Within-scanner movement data was examined for all subjects and no subject 
was found to have moved more than 3.0mm in any axis across the duration of the scan. 
Before fitting the model, the subject’s data were filtered in time using a high pass 
filter (150 s cut-off) and temporal autocorrelations were accounted for by imposing an 
AR(1) model.
Statistical analysis was performed using the general linear model approach as 
implemented in SPM2. At the individual participant level the data for each task were 
modelled with three conditions (fear, neutral and baseline) each modelled by a boxcar 
convolved with a canonical haemodynamic response function. Parameters 
representing the participants movement during the scan were also entered into the 
model as covariates of no interest. Contrast images were generated for each 
participant for the contrasts of interest (fear versus neutral, fear versus baseline and 
neutral versus baseline) representing the pair-wise comparison of parameter estimates 
for the conditions. One contrast image per participant was then entered into a second-
level random effects analysis for each contrast of interest to examine regions of 
significant difference between groups using a two sample t-test. 
All statistical maps were thresholded at a level of P<0.001 uncorrected and 
regions were considered significant at P<0.05 at the cluster level, corrected for 
multiple comparisons. Co-ordinates were converted from MNI to Talairach co-
ordinates using a non-linear transformation (http://www.mrc-cbu.cam.ac.uk/Imaging). 
A region of interest (ROI) analysis was conducted for the bilateral amygdala using a  
mask derived from the automated anatomical labelling atlas in WFU_PickAtlas v2.0 
(8, 9).
Functional connectivity analysis
Time series were extracted from spheres (radius 5mm) centred on voxels of peak 
difference in the amygdala and fusiform gyrus for the fear versus neutral contrast. 
These data were regressed against motion parameters, and time series extracted from 
white matter and CSF, to reduce the effects of noise unrelated to the task. Pearson 
correlation coefficients were then calculated between the regions of interest and 
transformed to normal space using Fisher's r-to-z. The conditions of interest were 
considered separately by truncating the timecourses according to condition blocks. 
Independent t-tests were then performed between the patient and control groups to 
compare connectivity across the conditions. 
Behavioural tests of emotion recognition
A well charactersised behavioural test of facial emotion recognition was conducted 
after the scanning session (10-13). Photographs of the faces of 10 people used in this 
test were taken from the Ekman and Friesen series (4). For each face, there were poses 
corresponding to each of 6 basic emotions (happiness, surprise, fear, sadness, disgust, 
and anger), giving a total of 60 photographs (10 for each emotion). These were shown 
one at a time on a computer screen in pseudo-random order, for 3 seconds each. The 
task involved deciding which of the emotion names (happiness, surprise, fear, sadness, 
disgust, or anger) best described the facial expression shown. All participants were 
asked if they understood the meanings of the emotional names.  If not, brief 
standardised descriptions were given. The names of the six emotions were displayed 
at the bottom of the screen and they could be consulted throughout the test. The order 
of the emotions on the screen was varied between tests. Responses were made by 
clicking the computer mouse over the name of the selected emotion. There was no 
time limit for responding. The next face was not shown until the subject had made a 
response.  No feedback was given as to the appropriateness of any responses. Results 
were analysed using SPSS for Windows (version 14.0, SPSS Inc., US).
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Supplementary Results
Examination of the pattern of functional connectivity between the amygdala and fusiform gyrus 
within the healthy control group across task conditions revealed greater connectivity in the baseline
condition than in either the neutral or fear conditions (Supplementary Figure 2). The same overall 
pattern of connectivity was also seen within the patient group (Supplementary Figure 2). The 
patient group showed lower overall connectivity between the amygdala and fusiform gyrus that 
reached significance in the comparison of baseline connectivity (t(41)=2.4 p=0.021), although this 
effect would not survive correction for the number of comparisons made. This reflects previous 
findings of abnormalities in resting state connectivity in schizophrenia (1). These results however 
do not support the view that alterations in connectivity between the amygdala and fusiform gyrus 
account for the primary differences in amygdala activation in patients with schizophrenia reported 
in the present paper.
1. Zhou Y, Liang M, Tian L, Wang K, Hao Y, Liu H, et al. (2007): Functional disintegration in 
paranoid schizophrenia using resting-state fMRI. Schizophrenia Research. 97:194.
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Supplementary Figure 1. Plots of left amygdala activation within a VOI (8mm 
sphere of centre -22 -1 -12) for both task runs in the contrasts of A) Neutral versus 
Baseline, B) Fear versus Baseline. CON = control group. SCH = schizophrenia group. 
Error bars show SEM.
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Supplementary Figure 2. Functional connectivity between the amygdala (5mm 
sphere of centre -22 -1 -12) and the fusiform gyrus (5mm sphere of centre 33 -39-11). 
B = Baseline (rest) condition, N = Neutral condition, F = Fear condition. CON = 
control group. SCH = schizophrenia group. Error bars show SEM.
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